Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have earned an average rating of “Moderate Buy” from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $40.71.

SGRY has been the subject of a number of recent research reports. UBS Group initiated coverage on shares of Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 price objective for the company. StockNews.com cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Benchmark reissued a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a research note on Monday, August 26th. Citigroup dropped their price objective on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th. Finally, Macquarie dropped their price objective on shares of Surgery Partners from $35.00 to $34.00 and set an “outperform” rating for the company in a research note on Wednesday, November 13th.

Surgery Partners Stock Performance

SGRY opened at $21.83 on Tuesday. The stock has a market capitalization of $2.77 billion, a price-to-earnings ratio of -45.48, a PEG ratio of 16.86 and a beta of 2.76. The company has a fifty day moving average of $30.62 and a 200 day moving average of $28.48. Surgery Partners has a fifty-two week low of $21.54 and a fifty-two week high of $36.92. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.69 and a current ratio of 1.80.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). The company had revenue of $770.40 million for the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business’s revenue was up 14.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.15 earnings per share. As a group, sell-side analysts forecast that Surgery Partners will post 0.83 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Surgery Partners

Several large investors have recently added to or reduced their stakes in SGRY. Janus Henderson Group PLC boosted its position in Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after buying an additional 2,473,282 shares during the period. Deerfield Management Company L.P. Series C boosted its position in Surgery Partners by 47.7% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock valued at $111,986,000 after buying an additional 1,520,484 shares during the period. King Street Capital Management L.P. purchased a new stake in Surgery Partners in the 3rd quarter valued at about $46,748,000. Point72 Asset Management L.P. purchased a new stake in Surgery Partners in the 2nd quarter valued at about $29,288,000. Finally, Victory Capital Management Inc. boosted its position in Surgery Partners by 140.4% in the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after buying an additional 777,038 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.